SlideShare a Scribd company logo
BIG DIFFERENCES BETWEEN GENOTYPES AND OVER TIME. Between 600 and 750 probes were differently expressed
between infected and uninfected cattle. Principle component analysis of the expression data clearly shows genome-wide
differences between the transcriptomes of tolerant (×) and susceptible ( ) cattle (Top Right, PCA component 3) and some of these
differences are associated with the presence and progression of trypanosome infection (Top left, PCA component 1).
This image cannot currently be displayed.
This image cannot currently be displayed.
Genomics approaches to trypanosomiasis resistance
Breeds of cattle which are resistant and susceptible to pathology following Trypanosoma congolense infection, show
differences in gene expression following challenge. Examination of the networks of genes responding most
differently between these genotypes provides insights into the biology of the response to infection.
Where differentially used networks include genes within QTL for resistance, those genes become functional
candidates irrespective of whether they are differentially expressed themselves. The diversity of cattle and disease
challenge across Africa provides a unique natural experiment which can be used to evaluate these genes for
evidence of a functional role in trypanosome resistance.
The responding networks provide new ways of examining the pathology, raising hypotheses and suggesting novel
interventions which may be unrelated to the present diversity represented by the QTL.
GeneGo was used to identify networks amongst the
genes that were differentially expressed. The figure
(right) shows the largest network of connected genes that
were differently expressed by trypanosome infected
resistant (N’Dama) and susceptible (Boran) cattle.
STAT3 and c-Fos have the most connectivity. STAT3 is a
transcription factor which is activated in response to the
IL-6 family of cytokines and is involved in the acute
phase response in the liver
Interestingly, STAT3 is modulated by RAC1 which is in
turn controlled by VAV1 and ARHGAP15 which are both
located in the QTLs controlling trypanotolerance.
 Different cattle genotypes show differences in gene expression before and during trypanosome infection.
 Trypanosome infection induces profound changes in the steady state level of many genes.
 Network-based analysis reveals some highly concordantly responding networks
 Genes that are within QTL and also within highly connected networks are strong candidates for QTL genes
 Some differentially expressed genes are highly connected to many other differentially expressed genes. These are key points
for intervention.
Twenty N’Dama (tolerant) cattle and 20 Boran (susceptible) cattle were challenged with a lethal dose of T. congolense. Liver
biopsy samples were taken from each individual in specified days prior to and post infection such that at each time point there
were samples from at least 5 Boran and 5 N’Dama.
The mRNA profiles were assayed using the Affymetrix 24K probe sets (B). The gene data were fed into an analysis workflow (C)
that integrates the expression measures, gene ontology, QTL information, and gene pathways data.
Agaba M1
Anderson S4
Archibald A4
Brass A2
Gibson J5
Hall L4
Hanotte O1
Hulme H2
Kemp SJ1,3
Mwakaya J1
Noyes, HA3
Ogugo M1
Rennie C3
Addresses
1International Livestock
Research Institute,
Box 30709 - 00100, Nairobi
Kenya
2The University of
Manchester
LF8 Kilburn Bldg, Oxford Rd
Manchester M13 9PL
UK
3School of Biological
Sciences,
University of Liverpool,
Liverpool, L69 7ZB, UK
4Roslin Institute,
Roslin,
Midlothian, EH25 9PS, UK
5The Institute for Genetics &
Bioinformatics, Hawkins
Homestead, University of
New England, Armidale,
NSW 2351, Australia
Acknowledgements:
We thank all the staff at the
ILRI large animal facility and
all colleagues in the
Welcome Trust Consortium
This work was supported by
the Wellcome Trust.
QTL with p<0.0043 FDR(10%)
PCV
Body weight
Parasitaemia
Hanotte et al PNAS 2003 7443-7448
-15
-10
-5
0
5
10
15
N’Dama (tolerant)
-15
-10
-5
0
5
10
15
Boran (susceptible)
A cross between relatively
susceptible Boran and resistant
N’dama has shown that each
breed carries 5 different QTL for
resistance, and these have been
mapped in an F2 cross.

More Related Content

What's hot

Poster Rough Draft- revised again
Poster Rough Draft- revised againPoster Rough Draft- revised again
Poster Rough Draft- revised againElizabeth Abe
 
Genome responses of trypanosome infected cattle
Genome responses of trypanosome infected cattleGenome responses of trypanosome infected cattle
Genome responses of trypanosome infected cattle
Laurence Dawkins-Hall
 
Diner_oyster
Diner_oysterDiner_oyster
Diner_oyster
sr320
 
Bio380 Cancer Phylogenomics
Bio380 Cancer PhylogenomicsBio380 Cancer Phylogenomics
Bio380 Cancer Phylogenomics
Mark Pallen
 
Yeast two hybrid
Yeast two hybrid Yeast two hybrid
Yeast two hybrid
vruddhi desai
 
Regulatory b cells and tolerance in transplantation from animal models to hum...
Regulatory b cells and tolerance in transplantation from animal models to hum...Regulatory b cells and tolerance in transplantation from animal models to hum...
Regulatory b cells and tolerance in transplantation from animal models to hum...Elsa von Licy
 
Undergraduate Research Grant
Undergraduate Research GrantUndergraduate Research Grant
Undergraduate Research GrantKaitlin Zoccola
 
Oncotarget Olga´s paper
Oncotarget Olga´s paperOncotarget Olga´s paper
Oncotarget Olga´s paperOlga Villamizar
 
mcr-1-IJAA (1)
mcr-1-IJAA (1)mcr-1-IJAA (1)
mcr-1-IJAA (1)Amal Eid
 
Genetic polymorphism
Genetic polymorphismGenetic polymorphism
Genetic polymorphism
manorama12
 
Synonymous mutations as drivers in human cancer genomes.
Synonymous mutations as drivers in human cancer genomes.Synonymous mutations as drivers in human cancer genomes.
Synonymous mutations as drivers in human cancer genomes.
Fran Supek
 
Multigenic (mechanistic) biomarkers
Multigenic (mechanistic) biomarkersMultigenic (mechanistic) biomarkers
Multigenic (mechanistic) biomarkers
Joaquin Dopazo
 
20091201 Transfer Seminar Final
20091201 Transfer Seminar Final20091201 Transfer Seminar Final
20091201 Transfer Seminar Final
marcus314
 
Biochemistry Poster
Biochemistry PosterBiochemistry Poster
Biochemistry Poster
Zachary M. Weisner
 
Malaria disease
Malaria disease Malaria disease
Malaria disease
manorama12
 

What's hot (19)

Poster Rough Draft- revised again
Poster Rough Draft- revised againPoster Rough Draft- revised again
Poster Rough Draft- revised again
 
Genome responses of trypanosome infected cattle
Genome responses of trypanosome infected cattleGenome responses of trypanosome infected cattle
Genome responses of trypanosome infected cattle
 
Diner_oyster
Diner_oysterDiner_oyster
Diner_oyster
 
Bio380 Cancer Phylogenomics
Bio380 Cancer PhylogenomicsBio380 Cancer Phylogenomics
Bio380 Cancer Phylogenomics
 
Yeast two hybrid
Yeast two hybrid Yeast two hybrid
Yeast two hybrid
 
Regulatory b cells and tolerance in transplantation from animal models to hum...
Regulatory b cells and tolerance in transplantation from animal models to hum...Regulatory b cells and tolerance in transplantation from animal models to hum...
Regulatory b cells and tolerance in transplantation from animal models to hum...
 
Undergraduate Research Grant
Undergraduate Research GrantUndergraduate Research Grant
Undergraduate Research Grant
 
Oncotarget Olga´s paper
Oncotarget Olga´s paperOncotarget Olga´s paper
Oncotarget Olga´s paper
 
mcr-1-IJAA (1)
mcr-1-IJAA (1)mcr-1-IJAA (1)
mcr-1-IJAA (1)
 
Genetic polymorphism
Genetic polymorphismGenetic polymorphism
Genetic polymorphism
 
Synonymous mutations as drivers in human cancer genomes.
Synonymous mutations as drivers in human cancer genomes.Synonymous mutations as drivers in human cancer genomes.
Synonymous mutations as drivers in human cancer genomes.
 
Multigenic (mechanistic) biomarkers
Multigenic (mechanistic) biomarkersMultigenic (mechanistic) biomarkers
Multigenic (mechanistic) biomarkers
 
The interferons and their receptors – distribution and
The interferons and their receptors – distribution andThe interferons and their receptors – distribution and
The interferons and their receptors – distribution and
 
20091201 Transfer Seminar Final
20091201 Transfer Seminar Final20091201 Transfer Seminar Final
20091201 Transfer Seminar Final
 
Chen 2008
Chen 2008Chen 2008
Chen 2008
 
Monocyte recruitment into atherosclerotic plaques
Monocyte recruitment into atherosclerotic plaquesMonocyte recruitment into atherosclerotic plaques
Monocyte recruitment into atherosclerotic plaques
 
079 monocyte recruitment into atherosclerotic plaques
079 monocyte recruitment into atherosclerotic plaques079 monocyte recruitment into atherosclerotic plaques
079 monocyte recruitment into atherosclerotic plaques
 
Biochemistry Poster
Biochemistry PosterBiochemistry Poster
Biochemistry Poster
 
Malaria disease
Malaria disease Malaria disease
Malaria disease
 

Similar to Genomic approaches to trypanosome resistance

Systemic analysis of data combined from genetic qtl's and gene expression dat...
Systemic analysis of data combined from genetic qtl's and gene expression dat...Systemic analysis of data combined from genetic qtl's and gene expression dat...
Systemic analysis of data combined from genetic qtl's and gene expression dat...
Laurence Dawkins-Hall
 
Src jbbr-20-120 Dr. ihsan edan abdulkareem alsaimary PROFESSOR IN MEDICAL M...
Src jbbr-20-120  Dr. ihsan edan abdulkareem alsaimary  PROFESSOR IN MEDICAL M...Src jbbr-20-120  Dr. ihsan edan abdulkareem alsaimary  PROFESSOR IN MEDICAL M...
Src jbbr-20-120 Dr. ihsan edan abdulkareem alsaimary PROFESSOR IN MEDICAL M...
dr.Ihsan alsaimary
 
Assessment of immunomolecular_expression_and_prognostic_role_of_tlr7_among_pa...
Assessment of immunomolecular_expression_and_prognostic_role_of_tlr7_among_pa...Assessment of immunomolecular_expression_and_prognostic_role_of_tlr7_among_pa...
Assessment of immunomolecular_expression_and_prognostic_role_of_tlr7_among_pa...
dr.Ihsan alsaimary
 
A systematic, data driven approach to the combined analysis of microarray and...
A systematic, data driven approach to the combined analysis of microarray and...A systematic, data driven approach to the combined analysis of microarray and...
A systematic, data driven approach to the combined analysis of microarray and...
Laurence Dawkins-Hall
 
Insights into the tumor microenvironment and therapeutic T cell manufacture r...
Insights into the tumor microenvironment and therapeutic T cell manufacture r...Insights into the tumor microenvironment and therapeutic T cell manufacture r...
Insights into the tumor microenvironment and therapeutic T cell manufacture r...
Thermo Fisher Scientific
 
Bioinformatics-driven discovery of EGFR mutant Lung Cancer
Bioinformatics-driven discovery of EGFR mutant Lung CancerBioinformatics-driven discovery of EGFR mutant Lung Cancer
Bioinformatics-driven discovery of EGFR mutant Lung CancerPreveenRamamoorthy
 
Proteomic Analysis of the Serum and Excretory-Secretary proteins of Trichinel...
Proteomic Analysis of the Serum and Excretory-Secretary proteins of Trichinel...Proteomic Analysis of the Serum and Excretory-Secretary proteins of Trichinel...
Proteomic Analysis of the Serum and Excretory-Secretary proteins of Trichinel...
AmalDhivaharS
 
characterization of FQ Non-susceptible S. Pyogenes
characterization of FQ Non-susceptible S. Pyogenescharacterization of FQ Non-susceptible S. Pyogenes
characterization of FQ Non-susceptible S. Pyogenes
camilomesa22
 
identification and characterization of FQ-non-susceptable S. Pyogenes
identification and characterization of FQ-non-susceptable S. Pyogenesidentification and characterization of FQ-non-susceptable S. Pyogenes
identification and characterization of FQ-non-susceptable S. Pyogenes
camilomesa22
 
The 'omics' revolution: How will it improve our understanding of infections a...
The 'omics' revolution: How will it improve our understanding of infections a...The 'omics' revolution: How will it improve our understanding of infections a...
The 'omics' revolution: How will it improve our understanding of infections a...
WAidid
 
Diversity of O Antigens within the Genus Cronobacter - Martina
Diversity of O Antigens within the Genus Cronobacter - MartinaDiversity of O Antigens within the Genus Cronobacter - Martina
Diversity of O Antigens within the Genus Cronobacter - MartinaPauline Ogrodzki
 
Shigella flexneri serotype 1c derived from serotype 1a by acquisition of gtrI...
Shigella flexneri serotype 1c derived from serotype 1a by acquisition of gtrI...Shigella flexneri serotype 1c derived from serotype 1a by acquisition of gtrI...
Shigella flexneri serotype 1c derived from serotype 1a by acquisition of gtrI...
Swee Seong TANG
 
Ceraseetal2021complete.pdf
Ceraseetal2021complete.pdfCeraseetal2021complete.pdf
Ceraseetal2021complete.pdf
AndreaCerase3
 
Seminario
Seminario Seminario
5. identificacion de genes
5. identificacion de genes5. identificacion de genes
5. identificacion de genesRafael Ospina
 

Similar to Genomic approaches to trypanosome resistance (20)

Systemic analysis of data combined from genetic qtl's and gene expression dat...
Systemic analysis of data combined from genetic qtl's and gene expression dat...Systemic analysis of data combined from genetic qtl's and gene expression dat...
Systemic analysis of data combined from genetic qtl's and gene expression dat...
 
Src jbbr-20-120 Dr. ihsan edan abdulkareem alsaimary PROFESSOR IN MEDICAL M...
Src jbbr-20-120  Dr. ihsan edan abdulkareem alsaimary  PROFESSOR IN MEDICAL M...Src jbbr-20-120  Dr. ihsan edan abdulkareem alsaimary  PROFESSOR IN MEDICAL M...
Src jbbr-20-120 Dr. ihsan edan abdulkareem alsaimary PROFESSOR IN MEDICAL M...
 
Assessment of immunomolecular_expression_and_prognostic_role_of_tlr7_among_pa...
Assessment of immunomolecular_expression_and_prognostic_role_of_tlr7_among_pa...Assessment of immunomolecular_expression_and_prognostic_role_of_tlr7_among_pa...
Assessment of immunomolecular_expression_and_prognostic_role_of_tlr7_among_pa...
 
Pone.0034901
Pone.0034901Pone.0034901
Pone.0034901
 
PIIS0016508514604509
PIIS0016508514604509PIIS0016508514604509
PIIS0016508514604509
 
A systematic, data driven approach to the combined analysis of microarray and...
A systematic, data driven approach to the combined analysis of microarray and...A systematic, data driven approach to the combined analysis of microarray and...
A systematic, data driven approach to the combined analysis of microarray and...
 
Insights into the tumor microenvironment and therapeutic T cell manufacture r...
Insights into the tumor microenvironment and therapeutic T cell manufacture r...Insights into the tumor microenvironment and therapeutic T cell manufacture r...
Insights into the tumor microenvironment and therapeutic T cell manufacture r...
 
1110.full
1110.full1110.full
1110.full
 
Bioinformatics-driven discovery of EGFR mutant Lung Cancer
Bioinformatics-driven discovery of EGFR mutant Lung CancerBioinformatics-driven discovery of EGFR mutant Lung Cancer
Bioinformatics-driven discovery of EGFR mutant Lung Cancer
 
Proteomic Analysis of the Serum and Excretory-Secretary proteins of Trichinel...
Proteomic Analysis of the Serum and Excretory-Secretary proteins of Trichinel...Proteomic Analysis of the Serum and Excretory-Secretary proteins of Trichinel...
Proteomic Analysis of the Serum and Excretory-Secretary proteins of Trichinel...
 
characterization of FQ Non-susceptible S. Pyogenes
characterization of FQ Non-susceptible S. Pyogenescharacterization of FQ Non-susceptible S. Pyogenes
characterization of FQ Non-susceptible S. Pyogenes
 
identification and characterization of FQ-non-susceptable S. Pyogenes
identification and characterization of FQ-non-susceptable S. Pyogenesidentification and characterization of FQ-non-susceptable S. Pyogenes
identification and characterization of FQ-non-susceptable S. Pyogenes
 
The 'omics' revolution: How will it improve our understanding of infections a...
The 'omics' revolution: How will it improve our understanding of infections a...The 'omics' revolution: How will it improve our understanding of infections a...
The 'omics' revolution: How will it improve our understanding of infections a...
 
Diversity of O Antigens within the Genus Cronobacter - Martina
Diversity of O Antigens within the Genus Cronobacter - MartinaDiversity of O Antigens within the Genus Cronobacter - Martina
Diversity of O Antigens within the Genus Cronobacter - Martina
 
Shigella flexneri serotype 1c derived from serotype 1a by acquisition of gtrI...
Shigella flexneri serotype 1c derived from serotype 1a by acquisition of gtrI...Shigella flexneri serotype 1c derived from serotype 1a by acquisition of gtrI...
Shigella flexneri serotype 1c derived from serotype 1a by acquisition of gtrI...
 
Ceraseetal2021complete.pdf
Ceraseetal2021complete.pdfCeraseetal2021complete.pdf
Ceraseetal2021complete.pdf
 
1506.full
1506.full1506.full
1506.full
 
Seminario
Seminario Seminario
Seminario
 
5. identificacion de genes
5. identificacion de genes5. identificacion de genes
5. identificacion de genes
 
FOXP3 abstract AACR 20052nd draft
FOXP3 abstract AACR 20052nd draftFOXP3 abstract AACR 20052nd draft
FOXP3 abstract AACR 20052nd draft
 

More from Laurence Dawkins-Hall

DSRG report 2001
DSRG report 2001DSRG report 2001
DSRG report 2001
Laurence Dawkins-Hall
 
An evaluation of methods used to sequence pGEM template within core facilitie...
An evaluation of methods used to sequence pGEM template within core facilitie...An evaluation of methods used to sequence pGEM template within core facilitie...
An evaluation of methods used to sequence pGEM template within core facilitie...
Laurence Dawkins-Hall
 
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...06 isafg p77 genome wide expression consequences of a disease resistance qtl ...
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...
Laurence Dawkins-Hall
 
Lab talk 181209 radioligand assay for validating in silico rel 1 antagonist h...
Lab talk 181209 radioligand assay for validating in silico rel 1 antagonist h...Lab talk 181209 radioligand assay for validating in silico rel 1 antagonist h...
Lab talk 181209 radioligand assay for validating in silico rel 1 antagonist h...
Laurence Dawkins-Hall
 
Lab talk 201109 radioligand assay for validating in slico predicted rel1 anta...
Lab talk 201109 radioligand assay for validating in slico predicted rel1 anta...Lab talk 201109 radioligand assay for validating in slico predicted rel1 anta...
Lab talk 201109 radioligand assay for validating in slico predicted rel1 anta...
Laurence Dawkins-Hall
 
Lab talk 180909 radioligand assay to validate in silico predicted rel1 inhib...
Lab talk 180909 radioligand assay to validate in silico predicted  rel1 inhib...Lab talk 180909 radioligand assay to validate in silico predicted  rel1 inhib...
Lab talk 180909 radioligand assay to validate in silico predicted rel1 inhib...
Laurence Dawkins-Hall
 
Lab talk 060809 radioligand assay to validate in slico predicted rel inhibito...
Lab talk 060809 radioligand assay to validate in slico predicted rel inhibito...Lab talk 060809 radioligand assay to validate in slico predicted rel inhibito...
Lab talk 060809 radioligand assay to validate in slico predicted rel inhibito...
Laurence Dawkins-Hall
 
Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat s...
Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat s...Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat s...
Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat s...
Laurence Dawkins-Hall
 
Labtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophores
Labtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophoresLabtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophores
Labtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophores
Laurence Dawkins-Hall
 
Lab talk 300710 optimisation of fret assay parameters_calculating km of atp s...
Lab talk 300710 optimisation of fret assay parameters_calculating km of atp s...Lab talk 300710 optimisation of fret assay parameters_calculating km of atp s...
Lab talk 300710 optimisation of fret assay parameters_calculating km of atp s...
Laurence Dawkins-Hall
 
Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with...
Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with...Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with...
Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with...
Laurence Dawkins-Hall
 
Lab talk 020410 inducing rel 1 to set up ht fret assay_progress
Lab talk 020410 inducing rel 1 to set up ht fret assay_progressLab talk 020410 inducing rel 1 to set up ht fret assay_progress
Lab talk 020410 inducing rel 1 to set up ht fret assay_progress
Laurence Dawkins-Hall
 
Lab talk 190210 efficacy studies on radioligand hits_beginnings of fret assay...
Lab talk 190210 efficacy studies on radioligand hits_beginnings of fret assay...Lab talk 190210 efficacy studies on radioligand hits_beginnings of fret assay...
Lab talk 190210 efficacy studies on radioligand hits_beginnings of fret assay...
Laurence Dawkins-Hall
 
Lab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assay
Lab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assayLab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assay
Lab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assay
Laurence Dawkins-Hall
 
Genomic analysis of a hypertensive qtl on rat chr 1
Genomic analysis of a hypertensive qtl on rat chr 1Genomic analysis of a hypertensive qtl on rat chr 1
Genomic analysis of a hypertensive qtl on rat chr 1
Laurence Dawkins-Hall
 
RNA editing as a drug target in tryp assay dev woodshole 2011
RNA editing as a drug target in tryp assay dev woodshole 2011RNA editing as a drug target in tryp assay dev woodshole 2011
RNA editing as a drug target in tryp assay dev woodshole 2011
Laurence Dawkins-Hall
 
RNA editing as a drug target in tryp assay dev woods_hole2_0411 acs v2
RNA editing as a drug target in tryp assay dev woods_hole2_0411 acs v2RNA editing as a drug target in tryp assay dev woods_hole2_0411 acs v2
RNA editing as a drug target in tryp assay dev woods_hole2_0411 acs v2
Laurence Dawkins-Hall
 
RNA editing as a drug target in tryp. development of a high throughput sceeni...
RNA editing as a drug target in tryp. development of a high throughput sceeni...RNA editing as a drug target in tryp. development of a high throughput sceeni...
RNA editing as a drug target in tryp. development of a high throughput sceeni...
Laurence Dawkins-Hall
 
Rna editing as a drug target identification of inhibitors of rel 1 bsp 2010
Rna editing as a drug target identification of inhibitors of rel 1 bsp 2010Rna editing as a drug target identification of inhibitors of rel 1 bsp 2010
Rna editing as a drug target identification of inhibitors of rel 1 bsp 2010
Laurence Dawkins-Hall
 
Rna editing as a drug target identification of inhibitors of rel 1 bsp 210
Rna editing as a drug target identification of inhibitors of rel 1 bsp 210Rna editing as a drug target identification of inhibitors of rel 1 bsp 210
Rna editing as a drug target identification of inhibitors of rel 1 bsp 210
Laurence Dawkins-Hall
 

More from Laurence Dawkins-Hall (20)

DSRG report 2001
DSRG report 2001DSRG report 2001
DSRG report 2001
 
An evaluation of methods used to sequence pGEM template within core facilitie...
An evaluation of methods used to sequence pGEM template within core facilitie...An evaluation of methods used to sequence pGEM template within core facilitie...
An evaluation of methods used to sequence pGEM template within core facilitie...
 
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...06 isafg p77 genome wide expression consequences of a disease resistance qtl ...
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...
 
Lab talk 181209 radioligand assay for validating in silico rel 1 antagonist h...
Lab talk 181209 radioligand assay for validating in silico rel 1 antagonist h...Lab talk 181209 radioligand assay for validating in silico rel 1 antagonist h...
Lab talk 181209 radioligand assay for validating in silico rel 1 antagonist h...
 
Lab talk 201109 radioligand assay for validating in slico predicted rel1 anta...
Lab talk 201109 radioligand assay for validating in slico predicted rel1 anta...Lab talk 201109 radioligand assay for validating in slico predicted rel1 anta...
Lab talk 201109 radioligand assay for validating in slico predicted rel1 anta...
 
Lab talk 180909 radioligand assay to validate in silico predicted rel1 inhib...
Lab talk 180909 radioligand assay to validate in silico predicted  rel1 inhib...Lab talk 180909 radioligand assay to validate in silico predicted  rel1 inhib...
Lab talk 180909 radioligand assay to validate in silico predicted rel1 inhib...
 
Lab talk 060809 radioligand assay to validate in slico predicted rel inhibito...
Lab talk 060809 radioligand assay to validate in slico predicted rel inhibito...Lab talk 060809 radioligand assay to validate in slico predicted rel inhibito...
Lab talk 060809 radioligand assay to validate in slico predicted rel inhibito...
 
Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat s...
Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat s...Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat s...
Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat s...
 
Labtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophores
Labtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophoresLabtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophores
Labtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophores
 
Lab talk 300710 optimisation of fret assay parameters_calculating km of atp s...
Lab talk 300710 optimisation of fret assay parameters_calculating km of atp s...Lab talk 300710 optimisation of fret assay parameters_calculating km of atp s...
Lab talk 300710 optimisation of fret assay parameters_calculating km of atp s...
 
Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with...
Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with...Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with...
Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with...
 
Lab talk 020410 inducing rel 1 to set up ht fret assay_progress
Lab talk 020410 inducing rel 1 to set up ht fret assay_progressLab talk 020410 inducing rel 1 to set up ht fret assay_progress
Lab talk 020410 inducing rel 1 to set up ht fret assay_progress
 
Lab talk 190210 efficacy studies on radioligand hits_beginnings of fret assay...
Lab talk 190210 efficacy studies on radioligand hits_beginnings of fret assay...Lab talk 190210 efficacy studies on radioligand hits_beginnings of fret assay...
Lab talk 190210 efficacy studies on radioligand hits_beginnings of fret assay...
 
Lab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assay
Lab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assayLab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assay
Lab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assay
 
Genomic analysis of a hypertensive qtl on rat chr 1
Genomic analysis of a hypertensive qtl on rat chr 1Genomic analysis of a hypertensive qtl on rat chr 1
Genomic analysis of a hypertensive qtl on rat chr 1
 
RNA editing as a drug target in tryp assay dev woodshole 2011
RNA editing as a drug target in tryp assay dev woodshole 2011RNA editing as a drug target in tryp assay dev woodshole 2011
RNA editing as a drug target in tryp assay dev woodshole 2011
 
RNA editing as a drug target in tryp assay dev woods_hole2_0411 acs v2
RNA editing as a drug target in tryp assay dev woods_hole2_0411 acs v2RNA editing as a drug target in tryp assay dev woods_hole2_0411 acs v2
RNA editing as a drug target in tryp assay dev woods_hole2_0411 acs v2
 
RNA editing as a drug target in tryp. development of a high throughput sceeni...
RNA editing as a drug target in tryp. development of a high throughput sceeni...RNA editing as a drug target in tryp. development of a high throughput sceeni...
RNA editing as a drug target in tryp. development of a high throughput sceeni...
 
Rna editing as a drug target identification of inhibitors of rel 1 bsp 2010
Rna editing as a drug target identification of inhibitors of rel 1 bsp 2010Rna editing as a drug target identification of inhibitors of rel 1 bsp 2010
Rna editing as a drug target identification of inhibitors of rel 1 bsp 2010
 
Rna editing as a drug target identification of inhibitors of rel 1 bsp 210
Rna editing as a drug target identification of inhibitors of rel 1 bsp 210Rna editing as a drug target identification of inhibitors of rel 1 bsp 210
Rna editing as a drug target identification of inhibitors of rel 1 bsp 210
 

Recently uploaded

Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
silvermistyshot
 
BLOOD AND BLOOD COMPONENT- introduction to blood physiology
BLOOD AND BLOOD COMPONENT- introduction to blood physiologyBLOOD AND BLOOD COMPONENT- introduction to blood physiology
BLOOD AND BLOOD COMPONENT- introduction to blood physiology
NoelManyise1
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
muralinath2
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
S.1 chemistry scheme term 2 for ordinary level
S.1 chemistry scheme term 2 for ordinary levelS.1 chemistry scheme term 2 for ordinary level
S.1 chemistry scheme term 2 for ordinary level
ronaldlakony0
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
Sérgio Sacani
 
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
yqqaatn0
 
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Studia Poinsotiana
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
muralinath2
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
IqrimaNabilatulhusni
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
Richard Gill
 
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityDeep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
University of Rennes, INSA Rennes, Inria/IRISA, CNRS
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
tonzsalvador2222
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
pablovgd
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
Columbia Weather Systems
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
fafyfskhan251kmf
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
University of Maribor
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
ChetanK57
 

Recently uploaded (20)

Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
 
BLOOD AND BLOOD COMPONENT- introduction to blood physiology
BLOOD AND BLOOD COMPONENT- introduction to blood physiologyBLOOD AND BLOOD COMPONENT- introduction to blood physiology
BLOOD AND BLOOD COMPONENT- introduction to blood physiology
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
S.1 chemistry scheme term 2 for ordinary level
S.1 chemistry scheme term 2 for ordinary levelS.1 chemistry scheme term 2 for ordinary level
S.1 chemistry scheme term 2 for ordinary level
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
 
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
 
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
 
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityDeep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
 

Genomic approaches to trypanosome resistance

  • 1. BIG DIFFERENCES BETWEEN GENOTYPES AND OVER TIME. Between 600 and 750 probes were differently expressed between infected and uninfected cattle. Principle component analysis of the expression data clearly shows genome-wide differences between the transcriptomes of tolerant (×) and susceptible ( ) cattle (Top Right, PCA component 3) and some of these differences are associated with the presence and progression of trypanosome infection (Top left, PCA component 1). This image cannot currently be displayed. This image cannot currently be displayed. Genomics approaches to trypanosomiasis resistance Breeds of cattle which are resistant and susceptible to pathology following Trypanosoma congolense infection, show differences in gene expression following challenge. Examination of the networks of genes responding most differently between these genotypes provides insights into the biology of the response to infection. Where differentially used networks include genes within QTL for resistance, those genes become functional candidates irrespective of whether they are differentially expressed themselves. The diversity of cattle and disease challenge across Africa provides a unique natural experiment which can be used to evaluate these genes for evidence of a functional role in trypanosome resistance. The responding networks provide new ways of examining the pathology, raising hypotheses and suggesting novel interventions which may be unrelated to the present diversity represented by the QTL. GeneGo was used to identify networks amongst the genes that were differentially expressed. The figure (right) shows the largest network of connected genes that were differently expressed by trypanosome infected resistant (N’Dama) and susceptible (Boran) cattle. STAT3 and c-Fos have the most connectivity. STAT3 is a transcription factor which is activated in response to the IL-6 family of cytokines and is involved in the acute phase response in the liver Interestingly, STAT3 is modulated by RAC1 which is in turn controlled by VAV1 and ARHGAP15 which are both located in the QTLs controlling trypanotolerance.  Different cattle genotypes show differences in gene expression before and during trypanosome infection.  Trypanosome infection induces profound changes in the steady state level of many genes.  Network-based analysis reveals some highly concordantly responding networks  Genes that are within QTL and also within highly connected networks are strong candidates for QTL genes  Some differentially expressed genes are highly connected to many other differentially expressed genes. These are key points for intervention. Twenty N’Dama (tolerant) cattle and 20 Boran (susceptible) cattle were challenged with a lethal dose of T. congolense. Liver biopsy samples were taken from each individual in specified days prior to and post infection such that at each time point there were samples from at least 5 Boran and 5 N’Dama. The mRNA profiles were assayed using the Affymetrix 24K probe sets (B). The gene data were fed into an analysis workflow (C) that integrates the expression measures, gene ontology, QTL information, and gene pathways data. Agaba M1 Anderson S4 Archibald A4 Brass A2 Gibson J5 Hall L4 Hanotte O1 Hulme H2 Kemp SJ1,3 Mwakaya J1 Noyes, HA3 Ogugo M1 Rennie C3 Addresses 1International Livestock Research Institute, Box 30709 - 00100, Nairobi Kenya 2The University of Manchester LF8 Kilburn Bldg, Oxford Rd Manchester M13 9PL UK 3School of Biological Sciences, University of Liverpool, Liverpool, L69 7ZB, UK 4Roslin Institute, Roslin, Midlothian, EH25 9PS, UK 5The Institute for Genetics & Bioinformatics, Hawkins Homestead, University of New England, Armidale, NSW 2351, Australia Acknowledgements: We thank all the staff at the ILRI large animal facility and all colleagues in the Welcome Trust Consortium This work was supported by the Wellcome Trust. QTL with p<0.0043 FDR(10%) PCV Body weight Parasitaemia Hanotte et al PNAS 2003 7443-7448 -15 -10 -5 0 5 10 15 N’Dama (tolerant) -15 -10 -5 0 5 10 15 Boran (susceptible) A cross between relatively susceptible Boran and resistant N’dama has shown that each breed carries 5 different QTL for resistance, and these have been mapped in an F2 cross.